Description

Enrofloxacin is a synthetic fluoroquinolone antibiotic with potent bactericidal activity against a broad spectrum of Gram-negative and Gram-positive pathogens. Its efficacy is critical for managing bacterial infections in veterinary medicine, ensuring animal health and productivity. This high-purity active pharmaceutical ingredient (API) is essential for manufacturers of veterinary pharmaceuticals, particularly in formulating injectable solutions, oral tablets, and medicated feed premixes for livestock, poultry, and companion animals.

Application

• Veterinary Pharmaceutical API: Primary active ingredient in injectable and oral formulations for treating bacterial infections.
• Livestock Health Management: Used for the treatment of respiratory, gastrointestinal, and systemic infections in cattle, swine, and poultry.
• Companion Animal Medicine: Formulated into tablets and topical solutions for dogs and cats to treat skin, urinary tract, and wound infections.
• Medicated Feed Additives: Incorporated into feed premixes for prophylactic and therapeutic use in aquaculture and poultry farming.
• Research & Development: Serves as a reference standard and key intermediate in antimicrobial research and new veterinary drug development.

Basic Information

Product Name	Enrofloxacin
CAS No.	93106-60-6
Molecular Formula	C19H22FN3O3
Molecular Weight	359.40 g/mol
Synonyms	Baytril; ENX; 1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; Ethyl 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylate; Ethyl 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate; Ethyl 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylate
EINECS	Contact for details

Quality Control

Our Enrofloxacin is manufactured under strict quality management systems to ensure it meets the stringent requirements for veterinary pharmaceutical ingredients. Each batch undergoes comprehensive analytical testing, including HPLC for assay and impurity profiling, to guarantee high purity and consistency. A Certificate of Analysis (COA) documenting identity, purity, and related substances is provided with every shipment, supporting compliance with cGMP and relevant pharmacopeial guidelines.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and light-sensitive; containers must be kept tightly sealed to minimize exposure to atmospheric moisture and light to maintain stability and potency.

Specification

Item	Specification
Appearance	White to slightly yellow crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.